Aarey Drugs & Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Aarey Drugs & Pharmaceuticals has a total shareholder equity of ₹1.2B and total debt of ₹373.7M, which brings its debt-to-equity ratio to 31.4%. Its total assets and total liabilities are ₹2.3B and ₹1.2B respectively. Aarey Drugs & Pharmaceuticals's EBIT is ₹73.9M making its interest coverage ratio 5.8. It has cash and short-term investments of ₹74.6M.
Key information
31.4%
Debt to equity ratio
₹373.74m
Debt
Interest coverage ratio | 5.8x |
Cash | ₹74.56m |
Equity | ₹1.19b |
Total liabilities | ₹1.15b |
Total assets | ₹2.34b |
Recent financial health updates
Recent updates
Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected
Apr 15Aarey Drugs & Pharmaceuticals (NSE:AAREYDRUGS) Has A Pretty Healthy Balance Sheet
Mar 22What Aarey Drugs & Pharmaceuticals Limited's (NSE:AAREYDRUGS) P/E Is Not Telling You
Dec 30Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS) Shares Fly 25% But Investors Aren't Buying For Growth
Dec 29Calculating The Fair Value Of Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS)
Aug 20Financial Position Analysis
Short Term Liabilities: AAREYDRUGS's short term assets (₹2.2B) exceed its short term liabilities (₹1.1B).
Long Term Liabilities: AAREYDRUGS's short term assets (₹2.2B) exceed its long term liabilities (₹52.2M).
Debt to Equity History and Analysis
Debt Level: AAREYDRUGS's net debt to equity ratio (25.2%) is considered satisfactory.
Reducing Debt: AAREYDRUGS's debt to equity ratio has increased from 14.1% to 31.4% over the past 5 years.
Debt Coverage: AAREYDRUGS's debt is not well covered by operating cash flow (0.8%).
Interest Coverage: AAREYDRUGS's interest payments on its debt are well covered by EBIT (5.8x coverage).